GlassScriptPhysician profile
James B Garnett
NPI 1922125053
$19,025.25
in general payments reported to CMS, 2019-2025
38 companies · $798 in 2025
The $798 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,770 · 2020: $1,718 · 2021: $1,547 · 2022: $4,109 · 2023: $1,857 · 2024: $3,227 · 2025: $798.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,662 · Travel and Lodging: $1,219.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,662.20 |
| Travel and Lodging | $1,219.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,604.73 | 2019-2025 | Mitraclip, Coroflow, Navitor |
| Edwards Lifesciences Corporation | $4,859.70 | 2019-2024 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| W. L. Gore & Associates, INC. | $4,395.90 | 2019-2025 | Gore Cardioform Septal Occluder |
| Novartis Pharmaceuticals Corporation | $522.69 | 2019-2025 | |
| Medtronic, INC. | $438.79 | 2022-2024 | Corevalve Evolut R |
| Medtronic Vascular, INC. | $404.73 | 2019-2020 | |
| Boston Scientific Corporation | $326.35 | 2020-2025 | Watchman Flx, Avvigo Guidance System |
| Angiodynamics, INC. | $246.23 | 2019-2024 | Alphavac, Angiovac |
| Amgen INC. | $238.88 | 2019-2023 | Repatha |
| Penumbra, INC. | $199.78 | 2022-2025 | Penumbra System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $191.78 | 2019-2025 | |
| Pfizer INC. | $170.22 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $167.74 | 2019-2024 | Xarelto |
| Sanofi-Aventis U.S. LLC | $138.02 | 2019-2022 | |
| Philips North America LLC | $116.15 | 2024-2025 | Diagnostic Ecg Service, (Ao0) Igt Devices Intracardiac |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $102.13 | 2019-2024 | Camzyos, Eliquis |
| Shockwave Medical, INC | $100.10 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Atricure, INC. | $94.34 | 2023-2024 | |
| Cardiva Medical, INC. | $93.57 | 2019-2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f, Savvywire |
| Cordis US Corp. | $65.03 | 2025 | Mynxgrip |
| Biosense Webster, INC. | $62.20 | 2020-2024 | Qdot Micro Catheter, Octaray Mapping Catheter |
| Cardiovascular Systems INC. | $59.80 | 2020-2022 | |
| Impulse Dynamics (USA) INC. | $45.58 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $42.84 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $40.34 | 2024 | Onpattro |
| Novo Nordisk INC | $39.26 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Scpharmaceuticals INC. | $38.50 | 2024-2025 | |
| Ancora Heart, INC. | $34.46 | 2024 | Accucinch |
| Actelion Pharmaceuticals US, INC. | $32.40 | 2024 | Opsumit, Uptravi |
| Genzyme Corporation | $22.20 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.45 | 2025 | |
| Abiomed | $18.57 | 2025 | |
| Esperion Therapeutics, INC. | $18.38 | 2021 | |
| Merck Sharp & Dohme LLC | $16.31 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $16.24 | 2025 | Lokelma |
| Regeneron Healthcare Solutions, INC. | $15.64 | 2019 | |
| Livanova USA, INC. | $14.24 | 2020 | |
| Itamar Medical INC | $11.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Garnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.